Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Autonomous Reanimation Company (ARC) is a medical technology firm focused on developing an automated, portable extracorporeal membrane oxygenation (ECMO) system designed for rapid deployment in emergency settings. The company's primary goal is to democratize access to advanced life support by simplifying the complex ECMO procedure, allowing it to be initiated by non-specialists outside of traditional intensive care units. Their platform integrates advanced sensors and autonomous control algorithms to manage blood flow and oxygenation, potentially improving survival rates for patients suffering from sudden cardiac arrest or severe respiratory failure. ARC aims to bridge the gap between initial resuscitation efforts and definitive hospital care through its innovative reanimation technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Autonomous Reanimation.